Compare Marathon Digital Holdings Inc (MARA) vs Novartis AG (NVS) Price & Performance

Marathon Digital Holdings (MARA) trades at $9.95, up 4.08% today but remains under pressure with a bearish technical signal. The company reported a Q2 2026 net loss of $1.60 per share, missing estimates, as revenue fell to $804 million with a net income margin of -429.71%. Despite negative cash flow from operations, MARA is pivoting toward AI digital infrastructure, appointing new directors to support growth. Analyst consensus is mixed with a $16.08 price target but high volatility persists.

MARA's outlook is challenged by persistent losses and high execution risk in its strategic shift, though its low P/E of 3.37 suggests deep value if the AI pivot succeeds. Key risks include Bitcoin price sensitivity, competitive pressures, and cash burn. Investors should weigh the 50% buy rating against fundamental weaknesses before considering a position.

Novartis AG (NVS) trades at $156.79, up 0.29% today, with a bullish technical signal from moving averages and recent Q2 2026 earnings beating estimates. Strong profitability is evident with a 74.74% gross margin and 22.5% net margin, while revenue grew to $56.67B in 2025. The stock faces resistance near $157, with support at $156.

The outlook is positive due to robust drug pipeline progress and reaffirmed 2026 guidance, though risks include generic competition for Entresto and pricing pressures. Analyst sentiment is mixed with 24% buy ratings, but institutional buying activity supports confidence in long-term growth.